Asimov Patents

Patent portfolio assigned to Asimov (verified via public assignee records). Asimov, Inc., Boston MA, founded 2017 - synthetic biology / genetic design automation (cells, genes, CAD software for biologics & gene therapies); matches industrials/US. CB Insights lists Ginkgo Bioworks as a synthetic-biology competitor. Own site names a16z/DARPA/MIT/NIST/BU as backers/collaborators but no pharma customers by name (says partners with 25+ companies/top-10 pharmas, unnamed). Patents CONFIRMED via Justia 'Patents Assigned to Asimov, Inc.' (genetic vectors, CAR-T/chimeric receptors) and PatSnap Synapse; exact count not reliably retrieved (Justia/Google Patents returned 403/503), so patent_count_estimate left at 0=unknown.